Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT01885130
NCT01885130CompletedNot Applicable

100 Human Subject Repeat Insult Patch Test Skin Irritation/Sensitization Evaluation (Occlusive Patch)

Galderma R&D0 sites100 target enrollmentStarted: December 1, 2012Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
100
Primary Endpoint
area of erythema and edema is measured
Study OverviewStudy DesignEligibility CriteriaArms & InterventionsOutcomesInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

Determine if Cetaphil Daily Advance Ultra Hydrating Lotion proves to be a contact sensitizer or irritant in certain individuals.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Not currently under a doctor's care
  • •Free of dermatological or systemic disorder which would interfere with the results
  • •Free of any acute or chronic disease
  • •Will complete a preliminary medical history form and are in general good health
  • •Can read, understand, and sign informed consent

Exclusion Criteria

  • •Under 18 years old
  • •Currently under doctor's care
  • •currently taking any medication
  • •History of acute or chronic disease
  • •Diagnosed with chronic skin allergies
  • •Pregnant or lactating

Arms & Interventions

Cetaphil Daily Advance Ultra Hydrating Lotion

Experimental

All subjects receive Cetaphil Daily Advance Ultra Hydrating Lotion

Intervention: Cetaphil Daily Advance Ultra Hydrating Lotion (Other)

Outcomes

Primary Outcomes

area of erythema and edema is measured

Time Frame: 3 consecutive weeks

9 consecutive 24hr exposures for every Monday, Wednesday, and Friday for 3 consecutive weeks

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Similar Trials

Completed
Not Applicable
Patch Test Skin Irritation/Sensitization of Cetaphil Restoraderm Skin Restoring Body WashSkin Irritation
NCT01892410Galderma R&D100
Completed
Not Applicable
Repeat Insult Patch Test for Daily Advance Cetaphil Moisturizing LotionSkin Irritation
NCT01892423Galderma R&D146
Completed
Not Applicable
Patch Test Skin Irritation/Sensitization of Cetaphil Daily Facial Moisturizer SPF 50Skin Irritation
NCT01887860Galderma R&D100
Completed
Not Applicable
Repeat Insult Patch Test of Skin Irritation/Sensitization for Cetaphil Daily Facial CleanserSkin Irritation
NCT01888887Galderma R&D200
Completed
Not Applicable
14-Day Cumulative Irritation Patch Test in Subjects With Normal Skin - ChameleonDermal Irritation
NCT02737618Church & Dwight Company, Inc.35